Real time insider trading transaction history:
- Insiders are prohibited from making short-swing profits by trading their shares within 6 months of the registration or acquiring the shares.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
Common stock purchase or sale:
| Transaction Date |
Reported DateTime |
Company | Symbol | Insider Relationship |
Shares Traded |
Average Price |
Total Amount |
Shares Owned |
Filing |
| 2023-01-04 Sale |
2023-01-05 9:07 pm |
Denali Therapeutics Inc. | DNLI | Schuth Alexander O. COFO and Secretary |
2,912 | $28.7 | $83,574 | 765,497 (Indirect Direct) |
View |
| 2023-01-04 Sale |
2023-01-05 9:07 pm |
Denali Therapeutics Inc. | DNLI | Watts Ryan J. President and CEO |
5,029 | $28.73 | $144,483 | 2,692,118 (Indirect Direct) |
View |
| 2022-11-23 Sale |
2022-11-28 7:30 pm |
Denali Therapeutics Inc. | DNLI | Tessier-Lavigne Marc Director |
20,000 | $30.48 | $609,600 | 2,107,225 (Indirect Direct) |
View |
| 2022-11-01 Sale |
2022-11-03 5:37 pm |
Denali Therapeutics Inc. | DNLI | Tessier-Lavigne Marc Director |
20,000 | $30.27 | $605,463 | 2,127,225 (Indirect Direct) |
View |
| 2022-09-28 Sale |
2022-09-30 4:50 pm |
Denali Therapeutics Inc. | DNLI | Tessier-Lavigne Marc Director |
20,000 | $30.82 | $616,304 | 2,147,225 (Indirect Direct) |
View |
| 2022-08-23 Sale |
2022-08-25 6:11 pm |
Denali Therapeutics Inc. | DNLI | Tessier-Lavigne Marc Director |
20,000 | $31.61 | $632,282 | 2,167,225 (Indirect Direct) |
View |
| 2022-08-23 Sale |
2022-08-25 6:10 pm |
Denali Therapeutics Inc. | DNLI | Ho Carole Chief Medical Officer |
2,424 | $31.98 | $77,520 | 301,260 (Indirect Direct) |
View |
| 2022-08-19 Sale |
2022-08-23 4:48 pm |
Denali Therapeutics Inc. | DNLI | Watts Ryan J. President and CEO |
2,404 | $33.22 | $79,861 | 2,368,187 (Indirect Direct) |
View |
| 2022-08-19 Sale |
2022-08-23 4:47 pm |
Denali Therapeutics Inc. | DNLI | Krognes Steve E. Director |
2,253 | $33.22 | $74,845 | 999,468 (Indirect Direct) |
View |
| 2022-08-19 Sale |
2022-08-23 4:46 pm |
Denali Therapeutics Inc. | DNLI | Schuth Alexander O. COFO and Secretary |
2,576 | $33.22 | $85,575 | 583,929 (Indirect Direct) |
View |
| 2022-08-19 Sale |
2022-08-23 4:45 pm |
Denali Therapeutics Inc. | DNLI | Ho Carole Chief Medical Officer |
2,576 | $33.22 | $85,575 | 303,684 (Indirect Direct) |
View |
| 2022-07-25 Sale |
2022-07-27 6:49 pm |
Denali Therapeutics Inc. | DNLI | Tessier-Lavigne Marc Director |
20,000 | $35.61 | $712,110 | 2,187,225 (Indirect Direct) |
View |
| 2022-03-23 Sale(A) |
2022-06-28 3:07 pm |
Denali Therapeutics Inc. | DNLI | Tessier-Lavigne Marc Director |
20,000 | $33.83 | $676,583 | 2,261,239 (Indirect Direct) |
View |
| 2022-06-23 Sale |
2022-06-27 8:54 pm |
Denali Therapeutics Inc. | DNLI | Tessier-Lavigne Marc Director |
60,000 | $30.72 | $1,843,045 | 2,207,225 (Indirect Direct) |
View |
| 2022-03-23 Sale |
2022-03-25 5:57 pm |
Denali Therapeutics Inc. | DNLI | Tessier-Lavigne Marc Director |
20,000 | $33.83 | $676,583 | 2,261,239 (Indirect Direct) |
View |
| 2022-02-11 Sale |
2022-02-15 6:58 pm |
Denali Therapeutics Inc. | DNLI | Watts Ryan J. President and CEO |
9,491 | $34.72 | $329,528 | 2,370,591 (Indirect Direct) |
View |
| 2022-02-11 Sale |
2022-02-15 6:56 pm |
Denali Therapeutics Inc. | DNLI | Krognes Steve E. CFO and Treasurer |
2,560 | $34.69 | $88,806 | 970,221 (Indirect Direct) |
View |
| 2022-02-11 Sale |
2022-02-15 6:55 pm |
Denali Therapeutics Inc. | DNLI | Schuth Alexander O. COO and Secretary |
2,803 | $34.68 | $97,208 | 563,465 (Indirect Direct) |
View |
| 2022-02-11 Sale |
2022-02-15 6:53 pm |
Denali Therapeutics Inc. | DNLI | Ho Carole Chief Medical Officer |
2,918 | $34.71 | $101,284 | 283,760 (Indirect Direct) |
View |
| 2022-02-09 Sale |
2022-02-11 5:20 pm |
Denali Therapeutics Inc. | DNLI | Krognes Steve E. CFO and Treasurer |
1,296 | $37.09 | $48,073 | 972,781 (Indirect Direct) |
View |
| 2022-02-09 Sale |
2022-02-11 5:19 pm |
Denali Therapeutics Inc. | DNLI | Watts Ryan J. President and CEO |
2,719 | $37.55 | $102,104 | 2,380,082 (Indirect Direct) |
View |
| 2022-02-09 Sale |
2022-02-11 5:18 pm |
Denali Therapeutics Inc. | DNLI | Schuth Alexander O. COO and Secretary |
1,423 | $37.1 | $52,800 | 566,268 (Indirect Direct) |
View |
| 2022-02-09 Sale |
2022-02-11 5:16 pm |
Denali Therapeutics Inc. | DNLI | Ho Carole Chief Medical Officer |
1,423 | $37.1 | $52,791 | 286,678 (Indirect Direct) |
View |
Stock options: Exercise, Award, Grant, Conversion
| Transaction Date |
Reported DateTime |
Exercisable Expiration |
Company | Symnbol | Insider Relationship |
Shares Traded |
Conversion Price |
Shares Owned |
Filing |
| 2023-01-03 Option Award |
2023-01-05 9:07 pm |
N/A 2033-01-02 |
Denali Therapeutics Inc. | DNLI | Schuth Alexander O. COFO and Secretary |
164,480 | $0 | 765,497 (Direct) |
View |
| 2023-01-03 Option Award |
2023-01-05 9:07 pm |
N/A 2033-01-02 |
Denali Therapeutics Inc. | DNLI | Watts Ryan J. President and CEO |
328,960 | $0 | 2,692,118 (Direct) |
View |
| 2022-10-07 Exercise |
2022-10-12 4:05 pm |
N/A N/A |
Denali Therapeutics Inc. | DNLI | Schuth Alexander O. COFO and Secretary |
20,000 | $0.68 | 824,007 (Indirect) |
View |
| 2022-10-07 Exercise |
2022-10-12 4:05 pm |
N/A 2025-08-20 |
Denali Therapeutics Inc. | DNLI | Schuth Alexander O. COFO and Secretary |
20,000 | $0 | 824,007 (Direct) |
View |
| 2022-08-09 Option Award |
2022-08-11 7:22 pm |
N/A N/A |
Denali Therapeutics Inc. | DNLI | Ho Carole Chief Medical Officer |
22,500 | $0 | 306,260 (Direct) |
View |
| 2022-08-09 Option Award |
2022-08-11 7:21 pm |
N/A N/A |
Denali Therapeutics Inc. | DNLI | Schuth Alexander O. COFO and Secretary |
22,500 | $0 | 586,505 (Direct) |
View |
| 2022-07-19 Exercise |
2022-07-21 7:36 pm |
N/A N/A |
Denali Therapeutics Inc. | DNLI | Krognes Steve E. Director |
62,500 | $0.68 | 1,001,721 (Direct) |
View |
| 2022-07-19 Exercise |
2022-07-21 7:36 pm |
2022-07-19 2022-08-01 |
Denali Therapeutics Inc. | DNLI | Krognes Steve E. Director |
62,500 | $0 | 1,001,721 (Direct) |
View |
| 2022-06-02 Option Award |
2022-06-06 8:09 pm |
N/A 2032-06-02 |
Denali Therapeutics Inc. | DNLI | Schenkein David P Director |
23,945 | $0 | 86,736 (Direct) |
View |
| 2022-06-02 Option Award |
2022-06-06 8:09 pm |
N/A 2032-06-02 |
Denali Therapeutics Inc. | DNLI | Klein Peter S Director |
23,945 | $0 | 29,272 (Direct) |
View |
| 2022-06-02 Option Award |
2022-06-06 8:09 pm |
N/A 2032-06-02 |
Denali Therapeutics Inc. | DNLI | Tessier-Lavigne Marc Director |
23,945 | $0 | 2,285,184 (Direct) |
View |
| 2022-06-02 Option Award |
2022-06-06 8:09 pm |
N/A 2032-06-02 |
Denali Therapeutics Inc. | DNLI | Cole Douglas G. Director |
23,945 | $0 | 40,307 (Direct) |
View |
| 2022-06-02 Option Award |
2022-06-06 8:08 pm |
N/A 2032-06-02 |
Denali Therapeutics Inc. | DNLI | SATO VICKI L Director |
23,945 | $0 | 160,108 (Direct) |
View |
| 2022-06-02 Option Award |
2022-06-06 8:08 pm |
N/A 2032-06-02 |
Denali Therapeutics Inc. | DNLI | Cook Jennifer E. Director |
23,945 | $0 | 29,272 (Direct) |
View |
| 2022-06-02 Option Award |
2022-06-06 8:07 pm |
N/A 2032-06-02 |
Denali Therapeutics Inc. | DNLI | FLATLEY JAY T Director |
23,945 | $0 | 354,272 (Direct) |
View |
| 2022-06-02 Option Award |
2022-06-06 8:07 pm |
N/A 2032-06-02 |
Denali Therapeutics Inc. | DNLI | Thornberry Nancy Director |
23,945 | $0 | 26,456 (Direct) |
View |
Ownership |
2022-02-17 8:25 pm |
N/A N/A |
Denali Therapeutics Inc. | DNLI | Tessier-Lavigne Marc Director |
0 | $0 | 2,281,239 (Indirect) |
View |
| 2021-12-13 Ownership |
2022-02-17 8:25 pm |
N/A N/A |
Denali Therapeutics Inc. | DNLI | Tessier-Lavigne Marc Director |
200,000 | $0 | 2,281,239 (Direct) |
View |
| 2022-02-10 Exercise |
2022-02-11 5:19 pm |
N/A 2027-03-07 |
Denali Therapeutics Inc. | DNLI | Watts Ryan J. President and CEO |
70,749 | $0 | 2,380,082 (Direct) |
View |
| 2022-02-10 Exercise |
2022-02-11 5:19 pm |
N/A N/A |
Denali Therapeutics Inc. | DNLI | Watts Ryan J. President and CEO |
64,631 | $5.28 | 2,380,082 (Direct) |
View |
| 2022-02-10 Exercise |
2022-02-11 5:19 pm |
N/A N/A |
Denali Therapeutics Inc. | DNLI | Watts Ryan J. President and CEO |
6,118 | $9.6 | 2,380,082 (Direct) |
View |
| 2022-02-03 Option Award |
2022-02-07 6:54 pm |
N/A 2032-02-03 |
Denali Therapeutics Inc. | DNLI | Harris Erik Director |
27,476 | $0 | 27,476 (Direct) |
View |
| 2022-01-08 Option Award |
2022-01-11 7:54 pm |
N/A N/A |
Denali Therapeutics Inc. | DNLI | Thornberry Nancy Director |
627 | $0 | 2,511 (Direct) |
View |